Palatin Technologies
PTN
#9857
Rank
A$65.82 M
Marketcap
A$38.66
Share price
-8.37%
Change (1 day)
2,865.46%
Change (1 year)

Palatin Technologies (PTN) - Cash on Hand

Cash on Hand as of September 2025 : A$1.91 Million

According to Palatin Technologies's latest financial reports the company has A$1.91 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Palatin Technologies - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30A$14.27 M-13.38%
2023-06-30A$16.47 M-62.03%
2022-06-30A$43.4 M-45.85%
2021-06-30A$80.16 M-33.22%
2020-06-30A$0.12 B93.77%
2019-06-30A$61.95 M20.69%
2018-06-30A$51.33 M-2.57%
2017-06-30A$52.68 M318.24%
2016-06-30A$12.59 M-64.5%
2015-06-30A$35.48 M174.58%
2014-06-30A$12.92 M-51.69%
2013-06-30A$26.74 M615.79%
2012-06-30A$3.73 M-78.78%
2011-06-30A$17.6 M68.17%
2010-06-30A$10.46 M8.33%
2009-06-30A$9.66 M-27.65%
2008-06-30A$13.35 M-66.51%
2007-06-30A$39.88 M-3.79%
2006-06-30A$41.45 M74.71%
2005-06-30A$23.72 M-19.72%
2004-06-30A$29.55 M7.37%
2003-06-30A$27.52 M94.5%
2002-06-30A$14.15 M-36.78%
2001-06-30A$22.38 M150.3%
2000-06-30A$8.94 M111.18%
1999-06-30A$4.23 M-38.86%
1998-06-30A$6.92 M-59.14%
1997-06-30A$16.95 M96.51%
1996-06-30A$8.62 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
MediciNova
MNOV
A$49.06 M 2,457.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A$8.45 M 340.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.67 B 87,467.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.40 B 21,223.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.02 B 53,073.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.96 B 1,457,938.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.36 B 18,964.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$12.32 B 642,593.31%๐Ÿ‡ฌ๐Ÿ‡ง UK